Literature DB >> 28705699

Posterolateral Trajectories Favor a Longer Motor Domain in Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease.

Idit Tamir1, Odeya Marmor-Levin2, Renana Eitan3, Hagai Bergman4, Zvi Israel5.   

Abstract

OBJECTIVE: The clinical outcome of patients with Parkinson disease (PD) who undergo subthalamic nucleus (STN) deep brain stimulation (DBS) is, in part, determined by the length of the electrode trajectory through the motor STN domain, the dorsolateral oscillatory region (DLOR). Trajectory length has been found to correlate with the stimulation-related improvement in patients' motor function (estimated by part III of the United Parkinson's Disease Rating Scale [UPDRS]). Therefore, it seems that ideally trajectories should have maximal DLOR length.
METHODS: We retrospectively studied the influence of various anatomic aspects of the brains of patients with PD and the geometry of trajectories planned on the length of the DLOR and STN recorded during DBS surgery. We examined 212 trajectories and 424 microelectrode recording tracks in 115 patients operated on in our center between 2010 and 2015.
RESULTS: We found a strong correlation between the length of the recorded DLOR and STN. Trajectories that were more lateral and/or posterior in orientation had a longer STN and DLOR pass, although the DLOR/STN fraction length remained constant. The STN target was more lateral when the third ventricle was wider, and the latter correlated with older age and male gender.
CONCLUSIONS: Trajectory angles correlate with the recorded STN and DLOR lengths, and should be altered toward a more posterolateral angle in older patients and atrophied brains to compensate for the changes in STN location and geometry. These fine adjustments should yield a longer motor domain pass, thereby improving the patient's predicted outcome.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beta oscillations; DBS; Local field potential; Parkinson disease; STN; Trajectory

Mesh:

Year:  2017        PMID: 28705699     DOI: 10.1016/j.wneu.2017.06.178

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Deep Brain Stimulation of Subthalamic Nucleus in Parkinson's Disease.

Authors:  Bedia Samanci; Yavuz Samanci
Journal:  Noro Psikiyatr Ars       Date:  2020-11-27       Impact factor: 1.339

2.  A comparison of indirect and direct targeted STN DBS in the treatment of Parkinson's disease-surgical method and clinical outcome over 15-year timespan.

Authors:  Maija Johanna Lahtinen; Tarja Helena Haapaniemi; Mikko Tapio Kauppinen; Niina Salokorpi; Esa Raimo Heikkinen; Jani Petteri Katisko
Journal:  Acta Neurochir (Wien)       Date:  2020-02-26       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.